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A COMPARATIVE STUDY OF PLACENTAL MORPHOMETRY  
AND HISTOMORPHOLOGY IN NORMAL AND  
HYPERTENSIVE PREGNANCIES 
 
ABSTRACT 
 
 In preeclampsia, there is increased resistance to uteroplacental circulation which 
adversely affects the  placental morphology (macroscopically and microscopically) and in turn 
the fetal growth. 
 
OBJECTIVES :  
 To study the morphometry , gross and histomorphologic changes of placenta in 
preeclampsia & to correlate these changes with severity of preeclampsia , as well as fetal 
outcome. 
 
METHODS :   
 200 placentae (100 normal ; 100 preeclamptic ) were studied .Fetal outcome,   Placental 
morphometry,  gross and histomorphologic features were studied in the two groups and the 
results were compared and correlated using statistical analysis . 
 
RESULTS :  
 The placental weight , volume and surface area were significantly decreased in the 
preeclamptic group . The incidence of retroplacental hematoma and infarction  was significantly 
more in the study group and was also associated with a poor fetal outcome.  The microscopic 
features of areas of syncytial knot formation , cytotrophoblastic cellular proliferation , irregular 
thickening of trophoblastic basement membrane , villous fibrinoid degeneration and villous 
stromal fibrosis were all found in agreater amount in the preeclamptic placentae than the control 
group . And these changes statistically correlated with severity of preeclampsia , aswell as with 
fetal outcome . 
 
CONCLUSION :  
 Preeclampsia adversely influences the morphometry and morphology of the placenta with 
an impact on the fetal outcome. However, none of the pathological changes are specific to 
preeclampsia. This study further emphasizes the importance of in-utero measurement of 
placental volume and thus better management of at risk fetuses. 
 
KEY WORDS :  
 Placenta, preeclampsia, morphometry, morphology. 
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INTRODUCTION 
 
Placental pathology has undoubtedly received very little attention 
by both the obstetricians and pathologist .The various indications for 
placental examination  are essentially any maternal disease , or disorders 
of the infant or any other clinically accepted placental abnormality.1 
 
 A careful gross examination of the placenta with retention of 
formalin-fixed tissue can permit subsequent histologic examination in 
cases where an abnormality becomes apparent in neonatal life, rather than 
at birth. 1  
 
 Placental examination has been shown to be of immense clinical 
value in various cases that were selected because of gestational 
complications, unusual disorders of mother or infant, perinatal death, 
problems in perinatal diagnosis, and multiple pregnancies. 2 
 
 Placental examination forms an integral part of prenatal or fetal  
autopsy and helps in adding  important or conclusive information. 3  
 
 Examination of the placenta in a problematic pregnancy has its 
own value, it yields information regarding the nature and duration of 
processes that has occurred during the gestational period. Such evaluation 
requires thorough and thoughtful gross examination, careful sectioning, 
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and a clear understanding of the basic microscopic features and the 
numerous changes in a whole list of pathologic processes. 4  
 
 Toxemia of pregnancy is one of  the known leading cause of 
maternal mortality and stands to be  an important factor in terms of fetal 
wastage as well.5 They form one of the deadly triad along with 
hemorrhage and infection which together contribute to maternal 
morbidity and mortality. In addition, preeclamptic pregnancies are known 
to be associated with prematurity and fetal growth restriction, 
contributing largely to perinatal mortality and morbidity.  
 
 In India, preeclampsia has an incidence of 1.5%. In most of the 
previous studies, gross abnormalities of placenta have received undue 
attention and undeserved status. Recently, morphological changes in the 
chorionic villi have been proven to bear a strong relationship  with the 
fetal well-being.6 
 
 The placenta has been referred to as the mirror of intrauterine fetal 
experience. Not only that, it stays to be the best record of the prenatal 
experience of every infant. A glance at the literature reveals that the 
preeclampsia-eclampsia syndrome does exert its deleterious effects on the 
placenta.5 
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 Grossly, the preeclamptic placentae is lesser in weight, diameter  
and thickness, with an increase in the incidence of abnormal shape and 
cord insertion, with diminished fetoplacental ratio. Also there seems to be 
a higher incidence of infarction and retroplacental hematoma, in 
preeclamptic placentae. 
 
 The numerous placental changes bear a direct relation to severity 
and duration of the disease process. The fetal outcome is adversely 
influenced by the pathological changes in the placenta. 
 
 Thus there is a need for a thorough examination of placenta which 
may help in revealing the various abnormalities that  contribute to the 
disorder of pregnancy, toxemia, in the present study. This study is an 
attempt to observe and to compare the morphometric and the 
morphological features, both gross and microscopic in preeclamptic and 
normal placentae. 
  
Aims and Objectives 
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AIMS & OBJECTIVES 
 
1. To record the data on morphometry, morphology and histology of 
normal and preeclamptic placentae, respectively. 
 
2. To compare and analyse the placental morphometry and placental 
morphology (gross and microscopic ) in normal and hypertensive 
pregnancies. 
 
3. To correlate the severity of pre-eclampsia with morphometry  and 
extent of histomorphologic changes. 
 
4. To correlate the fetal outcome with morphometric findings of placenta 
 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
PLACENTAL DEVELOPMENT : 
Development of human placenta is initiated at the time when the 
fetal membranes have established stable and close contacts with the 
uterine endometrium, or in other words when the blastocyst implants.  
 
The placenta develops in three stages (7) 
1. Prelacunar stage 
2. Lacunar stage 
3. Villous stage 
 
Prelacunar stage: 
 The implanting blastocyst is made of around 107 to 256 cells (8,9) . 
The cells forming the outer wall surrounding the blastocystic cavity are 
called trophoblast. These trophoblastic cells are the ultimate forerunners 
of the fetal membranes, including the placenta. 
 
 The inner cell mass is called embryoblast and this pole of the 
cavity is called embryonic pole. The embryoblast gives rise to the 
embryo, umbilical cord and the amnion. Apart from these, the 
embryoblast’s mesenchyme and blood vessels also contribute to the 
formation of the placenta.(7) 
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 After invading the endometrium, the trophoblastic cells proliferate 
to form two layers.(10) 
- Outer syncytiotrophoblast 
- Inner cytotrophoblast 
 
 This initial stage where the outer syncytiotrophoblast forms a 
rather soiled mass is the ‘Prelacunar stage’.(11) 
 
Lacunar Stage: 
 At this stage, small vacuoles start appearing in the syncytium, 
which expand and coalasce to form a system of lacunae. The interventing 
pillars and lamellae of SCT are called trabeculae. 
 
 The trophoblastic wall at implantation pole is much thicker 
(Chorionfrondosum) as the formation of SCT started much earlier here 
and this forms the placenta. And the remaining circumferential thinner 
trophoblastic layer undergoes regressive transformations to form the 
smooth chorion (Chorionleavae), the fetal membranes.(9) 
 
 With the formation of lacunae, the trophoblastic covering is 
divided into three layers. 
a) Primary chorionic plate, which lies towards the blastocystic cavity. 
b) Lacunar system along with trabeculae. 
c) Trophoblastic shell that faces endometrium 
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 With further invasion, the maternal blood vessels are disintegrated 
by the invading SCT. With this maternal blood fills the lacunae.(9) 
Likewise, the walls of the disintegrating capillaries and spiral arteries are 
completely replaced by the basally expanding SCT in a step wise 
fashion(12).  
 
Early villous stage : 
 Once the maternal circulation is established, there is an increase in 
trophoblastic proliferation with further fusion. This paves way to the 
formation of primary villi, which are composed of buds or projection of 
SCT invaded by proliferating CT. With further branching, they  give rise 
to primitive villous trees, which are called anchoring villi when they 
remain in contact with trophoblastic shell. Now the lacunar system is 
called intervillous space. 
 
 Sooner, the extraembryonic mesenchyme present on the 
innersurface of primary chorionic plate begins to invade, leading to 
formation of secondary villi. 
 
 The expanding villous mesenchyme does not reach the basal part of 
the trophoblastic shell. These basal segments of the trabeculae persist in 
primary villous stages. There are referred to as cell columns. They are the 
source of extravillous CT. Similarly, in some free floating villi the 
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proliferating villous tips are not invaded by mesenchyme and these form 
the trophoblastic cell islands. 
 
 The appearance of first fetal capillaries in the mesenchyme marks 
the formation of the tertiary villi. These fetal capillaries get their origin 
from hemangioblastic progenitor cells which in turn are believed to 
differentiate from the mesenchyme(13,14). 
 
 The placenta always forms a barrier between the maternal and fetal 
circulation. This barrier is made of the following layers; 
 
1. SCT - Continuous layer lining the IVS and covering the villous 
surface. 
2. CT (Langhans cells.) 
3. Basal lamina of the trophoblastic layer. 
4. Connective tissue 
5. Fetal endothelium surrounded by basal lamina. 
 
TEMPORAL VARIATION IN VILLOUS STRUCTURE: 
Growth and maturation of the villous tree 
 This temporal variation in villous structure is a reflection of the 
ongoing maturation and branching of the villous tree. And this  relation 
was formally documented; mostly by the work of Kaufmann and his 
colleagues (15-22). 
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There are five types of vill: 
1. Mesenchymal villi: 
a. These represent the first generation of any newly formed villi. 
b. Derived from mesenchymal invasion and vascularisation of 
trophoblastic sprouts. 
c. Differentiate into : mature or immature intermediate villi. 
d. Trophoblastic layer : complete, syncytial nuclei is dispersed 
regularly. 
e. Stroma : Immature and abundant with few hofbauer cells  and 
ill formed fetal capillaries. 
f. Time Scale : Mainly during early pregnancy. At term – few are 
seen in the centre of lobules. 
 
2. Immature intermediate villi: 
o These are stem villi’s peripheral extensions. 
o Trophoblastic layer: 
 Well preserved 
 Numerous CT 
 SCT nuclei evenly dispersed 
 No syncytial knots or vasculosyncytial membranes. 
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o Stroma: 
 Abundant and loose with numerous hofbauer cells; 
venules, arterioles and capillaries. 
o Time scale: 
 Predominant form in immature placenta. 
 At term : some seen in the centre of the lobules 
representing persistant growth zone(23-26).  
 
3. Stem Villi 
 These are the stems that connect the villous tree to the chorionic 
plate. 
 Towards term, the trophoblastic layer is mostly replaced by 
fibrinoid. 
 They contain arteries and veins with appreciable muscle walls, 
surrounded in turn by a compact fibrous stroma. 
 At term : makes up 1/3rd of total villous volume. Maximally 
concentrated in the central subchorial part. 
 
4. Mature intermediate villi:  
 Derived from peripheral ramification of villous stems. 
 Differentiate into terminal villi 
 SCT : uniform no knots or VSM. 
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 Stroma : Loose stroma containing capillaries along with small 
arterioles and venules. 
 Term Placenta : constitutes 1/4th of the total villous volume. 
 
5. Terminal Villi: 
 Final, grape like outgrowths of mature intermediate villi. 
 SCT : Thin, syncytial nuclei dispersed irregularly, syncytial 
knots & VSM seen. 
 Stroma : Contains sinusoidally dilated capillaries filling most of 
the cross sectional diameter of the villi. 
 At term : constitutes 60% of the villi 
 Best differentiated for materno – fetal transfer. 
 
Pattern of development, as detailed by Kaufmann and his colleagues: 
- Early weeks of pregnancy : all villi are menenchymal villi. 
- 7th& 8th Weeks GA :  
Mesenchymal villi begin to transform into 
 
Immature intermediate villi 
(subsequenty transform into) 
 
Stem Villi 
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o End of 2nd trimester         : formation of further IIV stops. 
 
- Beginning of 3rtrimester : There occurs a “SWITCH”(27-28)  
- From “Branching angiogenesis”, which is responsible for IIV 
           formation. 
- To “Non Branching angiogenesis”, which is responsible for MIV 
formation characterized by long, ill branched capillary loops. 
- Soon after terminal villi develop from MIV & predominate at term. 
These form when longitudinal capillary growth overcomes 
longitudual villous growth. 
 
REGIONAL VARIATION  IN VILLOUS  MORPHOLOGY : 
At term, towards 
 Fetal surface : Stem villi & intermediate villi are prominent. 
 Basal plate  : terminal villi are prominent. 
 
The terminal villi  
  (Subchorial vs  basal plate) 29,30 
      Subchorial villi have: 
- More collagenous stroma 
- Thicker TBM 
- Fewer VSM 
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- Greater number of easily visible CT 
 
 Peripheral vs Central villi 
Peripheral villi have:- 
- More fibrotic stroma 
- Thicker TBM 
- Fewer VSM 
 
 These variations bear a relationship to the flow dynamics of 
maternal blood in IVS & subsequent villous oxygenation. 
 
NORMAL HISTOLOGY OF PLACENTA 
Basic Villous structure: 
 The microscopic appearance of placental villi varies according to 
gestational age and the stage of development of the villous tree. Despite  
these facts, the villi possess a basic structure which is independent of all 
these variables. 
 
The trophoblastic mantle is divided into 
a) Inner layer of cytotrophoblastic cells (Langhan’s cell). 
b) Outer layer of syncytiotrophoblast 
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CYTOTROPHOBLAST : 
 The Langhan’s cells appear ovoid, cuboidal or polyhredral with 
well defined cell borders, clear to slightly granular cytoplasm and a pale  
staining nucleus with finely dispersed chromatin. 
 
 These cells are quite prominent and complete in the 1st trimester 
but they are discontinuous and less conspicuous in the 2nd and 3rd 
trimester. These are the stem cells which helps in the trophoblastic 
growth by promoting proliferation and subsequent fusion. 
 
 At term the CT is seen in only around 30% of the total villous 
surface. But this doesn’t mean that there is a decrease in the absolute 
number of CT at term, they continue to increase during the entire length 
of pregnancy. (31) 
 
SYNCYTIOTROPHOBLAST : 
 The villi are ultimately covered by SCT. This is a surface epithelial 
layer which is bathed on its outer surface by the maternal blood. The final 
and ultimate decisive barrier that either limits or permits the various 
transplacental process is the SCT.  
 
 This syncytium is devoid of generative potency. This lack of 
necessity to take part in cell division, permits the entire metabolic activity 
of this tissue to be channelized to its transfer function.(32) 
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 SCT is formed by the fusion of neighbouring trophoblastic cells, 
that come in contact with the maternal tissue. And it is worth noting that 
this happens to be the one and only true syncytium occurring in the 
human body.  
 
 During the first trimester, the syncytial nuclei are smaller, darkly 
stained and regularly placed. Their cytoplasm is finely granular, 
homogenous or commonly vacuolated of which some vacuoles may 
contain lipid. Apart from this we can also see a delicate brush border on 
the surface of the young villi . 
 
 In the term placenta, the syncytial nuclei are dispersed 
irregularly and aggregate to form multinucleated protrusions from the 
villous surface. These are termed syncytial knots.  
 
 Syncytial knots, syncytial sprouts and syncytial buds belong to 
a rather heterogeneous group of specialization in SCT. But they share one 
feature in common, ie. Remarkable collection of nuclei. (33,34) 
 
 Syncytial sprouts actually represent the early stages in the 
formation of lateral villi. Those of them which don’t become a villi 
become predunculated and ultimately breaks off to enter the  intervillous 
space and then the maternal circulation.  
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           Syncytial Buds  are the free multinucleated bodies in the villous 
stroma. These occur as a result of separation of the invaginating 
trophoblast into the villous stroma(34). But there is always a possibility 
that these buds, could in reality represent the tangential rectioning of an 
indenting villous surface trophoblast. 
  
 Bared on the descriptions of Cantle et al and Huppertz et al(35,36), 
the criteria that has been suggested for differentiating between true 
specialization of trophoblastic layer and tangential sections is as follows : 
 
True syncytial sprouting  
- Arise due to trophoblastic proliferation  
 
They have 
- Smooth surfaces 
- Loosely scattered oval nuclei 
- Incidental syncytial bridges 
 
Degenerative, apoptotic, Knotting 
They have  
- Knot or sprout like structures with smooth surfaces 
- Devoid of microvilli 
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- Nuclei are densely packed showing extremely condensed 
chromatin 
 
Flat sections (syncytial knotting, Tenney, Parker changes) 
- Irregularly shaped and notched sprouts,  knots and bridges 
- Nuclear shapes are heterogenous which is characteristic for 
syncytiotrophoblast. 
- The apparent number of nuclei, increases with the thickness of the 
section.  
 
Syncytial bridges  
 Yet another finding that has had intense discussion is the syncytial 
bridges. This was first described by Langhans 1870. Following that this 
has been reported by Stieve (1936, 1941), Peter (1943, 1951), Ortman 
(1941) ,Jones and Fox (1977) and Kaufmann &Stegner (1972).(37-44) 
 
 Studies by Kusterman (1981), Burton (1986a) Cantle et al (1987) 
concluded that these are artifacts due to tangential sectioning of villous 
branches. (35,45,46) 
 
 However, the studies by Burton and cantle et al (1987) have clearly 
stated and convinced that apart from artifactual effects, real syncytial 
bridges do exist.  
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 Evidence was provided by the studies of Kaufmann & Stegner 
(1972) Jones, & fox (1977) Horman (1953) and Cantle et al (1987) , 
stating that true bridges are a consequence of fusion of neighbouring 
villous surfaces, which have a prolonged close contact(35,43-44,47). Initially, 
the intercellular gaps between the adjacent villi are bridged through 
desmosomes. On a later stage, these distinguishing membranes 
disintegrate leading to the formation of true syncytial bridges.  
 
Syncytial knotting – influence by the section thickness(35,45-46)   
- Ultrathin sections (0.05 – 0.1mm) made for electron microscopy : 
exhibits very few sprouts or knot like findings. 
- In semithin functions, these findings are rare.  
- Paraffin section (5-10 mm) shows syncytial knotting as a frequent 
feature owing to its thickness.  
 
Syncytial knotting : Diagnostic value 
 Despite various studies referring this as sectional artifact, Kaufman 
et al (1987) stood by the fact that syncytial knotting as a two dimensional 
finding still has a diagnostic value.(48) 
 
 These can be considered as significant artifacts that point to an 
underlying deformity in the terminal villi. This can further be attributed to 
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abnormal villous angiogenesis due to defective oxygenation of the 
placenta as in hypoxic or preclamptic placentae. 
 
 Apart from structural changes, the two factors that can be helpful in 
differentiating between true sprouting, apoptotic knotting & trophoblastic 
flat sectioning are :- 
 Stage of pregnancy 
 Type of villi involved 
 
 Young placenta with sprouts arising from immature intermediate 
and mesenchymal villi represents signs of actual villous sprouting.  
 
In contrast,  in term placenta a vast majority of the knots are due to 
flat sectioning and these are found in aggregates of terminal villi which 
arise from the curved surface of a mature intermediate villi. But a 
minority of those emanating from immature intermediate villi present in 
the centre of villous trees is a representation of true villous sprouting.  
 
SCT is known to be a continuous structure in every placenta. Only 
during advanced pregnancy as a result of focal syncytiotrophoblastic 
degeneration,  fibrinoid plaques separate small islands of these SCT from 
the remaining syncytial continum. To be precise, wherever the SCT is 
interrupted due to degeneration, that gap is occupied by fibrin type 
fibrinoid.  
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TROPHOBLASTIC BASEMENT MEMBRANE  
 The villous trophoblast is limited from the villous stroma by the 
T.B.M.which on an average measures from 20 to 50mm thickness and has 
a fibrillary structure microscopically Its constituents are laminin collagen 
IV and heparin sulphate .(49) 
 
VILLOUS STROMA  
 This stroma is composed of undifferentiated mesenchymal cells, 
mature (retriculum) mesenchymal cells, fibroblasts, myofibroblasts, 
precollagen and collagen firbes. The relative proportion of these 
constituents vary with gestational age as well as stage of villous 
development(17,18,50-56). Few mast cells can also be present in the villous 
stroma (57,58). 
 
HofbauerCells : 
 These are simple tissue macrophages present in the villous 
stroma(59-61). These cells can be ovoid, round or reniform, measuring 
around 25µm in diameter with a nucleus placed eccentrically. The 
cytoplasm in the early stage of gestation is coarsely vacuolated but, as 
pregnancy advances, there is a decrease in the size and number of 
vacuoles with more prominence of the intracytoplasmic granules(62). 
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 Hofbauer cells are an important source of cytokines in the placenta. 
They mediate both non-immune and immune phagocytosis, as well as are 
capable of trapping maternal antibodies coming into the placental tissue. 
 
Fetal villous vessels: 
 The exact time of appearance of the first villous vessels is variable. 
Generally, by the second month end, well developed vessels that are lined 
with large, immature, endothelial cells are seen. The vessels of the 
terminal villi in term placenta are in capillary size, some can appear with 
sinusoidal dilatation. These endothelial cells are connected by tight 
functions and supported by the delicate basal lamina containing laminin, 
fibronection, and collagen type IV. (54,63) 
 
NON VILLOUS COMPONENTS 
 The placenta is limited on the fetal side by the amniotic membrane 
and chorionic plate and on maternal ride by the basal plate. In between 
these two, lies the intervillous space containing stem villi with their 
branches. 
 
Amnion:  
 It consists of a single layer of cubical epithelium loosely attached 
to the adjacent chorionic plate. It takes no  part in formation of the 
placenta and  is avascular. 
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Chorionic plate: 
From within outwards, it consists of 
1. Primitive chorionic mesoderm consisting of branches of umbilical 
vessels. 
2. A layer of CT. 
3. Syncytiotrophoblast: The stem villi arise from the plate. 
 
Basal Plate: 
From inside out, it consists of the following layers. 
1. Basal plate syncytiotrophoblast 
2. Rohr’s fibrinoid stria (encasing extra villous trophoblastic cells) 
3. Extravillous trophoblast layer 
4. Nitabuch’s fibrinoid layer (Uteroplacental fibrinoid) 
5. Part of the compact and spongy layer of the deciduasbasalis. 
 
 The basalplate is perforated by spiral artery branches of uterine 
vessels through which the maternal blood flows into the intervillous 
space. 
 
Intervillous space: 
 It is bounded on the inner side by the chorionic plate and on the 
outer side by the basal plate; limited on the periphery by the fusion of the 
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two  plates. It is lined internally on all sides by the SCT and is filled with 
slow flowing maternal blood.  
 
 Numerous branching villi, which arise from the stem villi and 
project into this space are the chief constituents of the IVS. 
 
Extravillous trophoblast cells: 
 This term applies to all the trophoblastic cells that lie outside the 
villi in the 
- Cell islands 
- Chorionic plate 
- Basal plate 
- Septa 
- Membranes 
- Cell column 
 
These are further categorized into  
- Proliferating stem cells (connected to the basal lamina) 
- Nonproliferating cells (have lost contact with basal llamina). 
 
Microscopic : 
 EVCT are either isolated or clustered in strings. They have a round 
to spindle or polygonal shape and in paraffin sections, their nuclear cross 
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sections are always seen. This point is of significance when trying to 
differentiate it from a decidual cell. 
 
Decidual Cells: 
 These are the stromal cells that are enlarged and elongated. In a 
section, all the cells will show the same shape depending on the angle at 
which the section was taken. Owing  to the elongated cell bodies, the cut 
section will rarely  include the ovoid nuclei. 
 
Uteroplacental veins: 
 These are seen admixed, within the decidual and extra villous 
trophoblastic cells, the trophoblastic cells might invade the venous wall, 
rarely, but  never invades the lumen of the uteroplacental vein. 
 
Uteroplacental arteries: 
 They traverse spirally in the basal plate and they serve the 
connection between the intervillous space and maternal uterine arteries. 
Owing to their spirality, we can see several cut sections of uteroplacental 
arteries. 
 
 As against the uteroplacental veins, a distinguisting feature of 
uteroplacental arteries is that their endothelial lining is to a great extent 
replaced by the cells termed “intravascular trophoblast”. These cells lead 
to the formations of large plugs that can either occlude or narrow the 
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arterial lumen. Sooner the adventitia as well as the media are also 
replaced by fibrinoid and trophoblastic cells. 
 
The placenta at term: 
 The expelled placenta is a flattened discoidal mass with an 
approximately circular or oval outline, with an : 
- Avg. volume 500ml (range 200-950 ml) 
- Avg. weight 500gms (range 200-800 gms) 
- Avg. diameter 185mm (range 150-200 mm) 
- Avg. thickness 23mm (range 10-40 mm) 
- Avg. Surface ara, 30,000mm 
 
 Thickest at its centre, it rapidly diminishes in thickness towards its 
periphery. 
 
Umbilical cord: 
 The normal length of umbilical cord at term is between 40 and 
70cm. Short cords are those less than 32cm and long cords are those more 
than 100cm. The normal coiling index is 1 coil / 5 cm. The cord contains, 
three vessels (two arteries and one vein) and this needs to be assessed at a 
minimum of 5cm from placental insertion. Embryonic remnants of the 
urachus  & vitelline duct are normal findings from which cysts can arise. 
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 These remnants may need to be differentiated from hemangiomas 
and teratomas. 
 
 The cord normally inserts near the centre than elsewhere. 
Battledore placenta with marginal insertion is seen in around 7% of term 
placentae and velamentous insertion in around 1% of term placentae. 
 
Extraplacental membranes and fetal surface 
 The significance of circumvallate and circummarginate placenta is 
uncertain .An association has been proposed between IUGR and acute 
and chronic maternal hemorrhage in circumvallate placentas. Amnion 
nodosum is a sign of oligohydramnios but sq. metaplasia of amnion is 
again a normal finding. 
 
 Langhan’s fribinoid (subchorionic fibrin deposition) in small, 
amounts is not pathological since it collects due to eddying of the 
intervillous flow. 
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FUNCTIONS OF THE PLACENTA: 
The placenta is a very unique organ as it takes charge of the 
function, of most of the fetal organs, with exception of the central 
nervous system and locomotor apparatus. The various functions 
accomplished by the placenta are:- 
 
a. Excretory function, pH regulations, water balance (kidney 
function). 
b. Gaseous exchange (Lung’s function) 
c. Resorptive and Catabolic function (Gut’s function) 
d. Synthesis and recreation of substances like the endocrine glands. 
e. Hematopoises (Bone marrow function) 
f. Numerous secretary and metabolic functions of the liver. 
 
PLACENTA  -  MACROSCOPIC FEATURES 
  Deviation from the round or oval shape such as irregularly 
shaped, multiobed or bilobed placenta may be attributed to uterine 
abnormalities or disturbed implantation. However this can be assessed 
only in clinicipathological context.  
 
The gross lesions of the placenta can be categorized as :  
1. Due to disturbances in maternal blood flow to or through the 
placenta.  
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2. Disturbances of fetal blood flow to or through  the placenta.  
3. Thrombi & hematomas.  
4. Non-vascular lesions. 
 
1. Lesions due to disturbances of maternal blood flow.  
a) Massive pervillous fibrin deposition : 
          Plaques of this fibrin is seen in around 22% of normal, 
uncomplicated full term placenta(64). This deposition is known to occur in 
the setting of a good maternal blood flow across the placenta.  
 
 Grossly, seen commonly in prepheral area in the marginal angle. It 
can also be present centrally. It is hard and sharply demarcated. The C/s 
is white or with a slight yellow tinge with a granular or smooth surface.  
 
Microscopically, this plaque contains widely separated villi 
entrapped in fibrin which obliterates the intervillous space completely. In 
older plaques, the SCT is lost, CT persist, TBM is thickened with 
progressive fibrosis of the villi making it avascular.  
 
B)  SubchorionicFibrin plaque : 
 This is seen in around 20% of normal, uncomplicated term 
placenta. This finding is unaffected by the maternal factors and does not 
interfere with fetal growth. These plaques are solely made of fibrin. This 
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deposition of fibrin is a consequence of maternal blood stasis in the 
subchorionic region of intervillous space(65).  
 
Gross : 
 Mostly a triangular sharply demarcated laminated white plaque 
with the base abutting the chorionic plate and apex pointing into placental 
substance.  
 
Microscopy : 
 The plaque is composed of solely laminated fibrin. No entrapped 
villi are seen.  
 
C) Maternal floor Infarction : 
 The incidence of this lesion has divergent views. As per Naeye , it 
occurs in 0.5% of placentas(66). But Andres et al said the incidence was 
only 0.09% and fox says, the incidence is even less. (67) 
 
 The etiology and pathogenesis of this finding is completely 
unknown. However, there are varying views. Rushton (1987) believed, 
these changes occur only after fetal death(68). As against this, sufficient 
cases associated with a healthy born infant have been reported (69,70). 
 
 Andres et al, 1990 ; Mandsager et al, (1994) Naeye (1988) believe 
it to be representative of an end period of various disorders(66,67,71) , whilst 
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Bernischke and Kaufmann (1995) said it could be caused by an abnormal 
host placental interaction(72).  
 
 There is a general agreement that this lesion is connected to IUGR 
and high incidence of fetal death probably because fibrin interferes with 
maternal blood perfusion of IVS(66,67,71,73,74) .  
 
Gross : 
 The matural surface is greyish yellow with a gyriform appearance. 
There is marked thickening of the basal plate with firm white material.  
 
Microscopy :  
 This lesion is compound of excess fibrin deposited in the basal 
plate, entrapped villi are seen within the expanding fibrin mass.  
 
D) Infarct  
 A placental infarct is defined as a localized region of  Ischaemic 
villous necrosis.  
 
 In normal uncomplicated term placentae,  less than 5% of villous 
tissue may be infarcted whereas in pre-edamptic placentae, the percentage 
is  > 5% of villous tissue.  
 
 There are various views regarding its etiology.  
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 Barthomew concluded that infarction is primarily due to an 
obstruction in the fetal stem vein with resultant congestion and swelling 
of villi finally leading to obliteration of IVS and their infarction. This 
view was supported by Hunt et al 1940, Falkiner 1942, Diekmann 1952, 
Steigrad 1952, Thomsen 1954, Gregor 1961, Becker 1963(75-81) . Further 
Roig (1963) said this obstruction occurs in umbilical vein due to cord 
knotting(82).  
 
 However over the years, various studies have accepted that 
thrombotic occlusion of the maternal uteroplacental vessel, some being 
secondary to a retro placental hematoma  is responsible for the placental 
infarct(83-93) .  
 
Gross : 
 Infarcts are more common in periphery than in central areas. The 
infarct is most of the times attached to the basal plate extending into the 
placental tissue. A fresh infarct is dark red and firmer with a shiny cut 
surface. Older infarcts are more firm and brown yellow or white in 
colour. 
 
Microscopy :  
 Early infarct is composed of crowded villi with extreme 
obliteration of IVS. The villous vessels are congested and dilated. The 
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SCT nuclei undergo pyknosis and eventually disappear. No TBM 
thickening or CT proliferation seen. Older infarct is composed of 
crowded ghost villi with a thin layer of intervening firbrin. 
 
II. Lesions due to fetal blood flow disturbances   
Fetal artery thrombosis : 
 Thrombotic occlusion of the fetal villous stem artery creates a 
sharply delineated area of villous avascularity. 
 
Incidence : 
 Fox  reported that single fetal artery thrombosis was seen in 4.5% 
of normal term placenta. There are no specific factors that predispose to 
thrombus formation.  
 
 The placenta can withstand the loss of upto 30% of its villi, 
provided the maternal circulation is intact. So, thrombus of a single fetal 
artery which will not deprive 75% of villi is of no significance.  
 
 However, they are found with increasing frequency in placenta 
from diabetic mother or maternal coagulation disorders(94,95). 
 
Gross : 
 Well delineated roughly triangular pallor area within the placental 
substance with the base facing the basal plate.  
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Microscopy : 
 This union appears as a sharply demarcated area of avascular villi. 
In these avascular villi,  
- SCT shows excessive knotting 
- CT : no proliferation 
- TBM : no thickening 
- Villous stroma : excessive stomal fibrous tissue. 
 
Intervillous space is patent with maternal blood. No fibrin deposition. 
 
III. Thrombi & Hematoma: 
A) Massive Subchorial thrombosis (Breus mole) 
 This is a red thrombus that measures around more than 1cm in 
thickness, separating the chorionic plate from underlying villous tissue. 
 
 Small subchorial thrombi are much more common than is generally 
recognized as they are easily missed or ignored.(96)  
 
 There has always been a controversy regarding its origin. Shanklin 
& Scot, (1975) reported that blood in the thrombus is of maternal origin. 
Whilst, Ho (1983) said it was of fetal origin as it has nucleated RBCs. 
Hart (1902) proposed that the reason could be a sudden marked slowing 
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of the blood flow in the IVS. Which is attributed to marked obliteration of 
venous channels draining the space.(97-99) 
 
Gross : 
 These appear as thick nodular masses of red thrombi distorting the 
fetal surface of placenta. It can extend to the basal plate to form a 
transplacental thrombus. 
 
Microscopy : 
 The lesion contains only laminated thrombus. No villi are seen 
within it. 
 
B) Retroplacental hematoma: 
 This lies between the uterine wall and the basal plate of placenta. 
 
 Fox reported its incidence as 4.5% of all placenta. This was the 
same as reported by Bermischke & Gille, (1977). Its incidence was 
however elevated in preeclampsia.(100,101) 
 
The various etiological factors proposed are; 
 Maternal hypertension & preeclampsia. 
 Obstruction to the venous drainage of placenta (102-105) . 
 Coccaine usage (106-110) 
 Cigarette Smoking (111-116) 
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 Anticardiolipin Antibodies (117) 
 Blunt trauma to abdomen (118,119) 
 
 The significance of the lesion depends on its size. Where as there 
can be an involvement of 20-25% of villous parenchyma without any 
untoward consequence of the fetus. 
 
Gross : 
 The lesion can extremely vary in size from 1 cm to fully involving 
the maternal surface. Frank hematoma is soft, red and can be easily 
detached from placental maternal surface leaving behind a crateriform 
depression. 
 
 Older hematoma appears brown, hard and firmly adherent to the 
placenta. ,compressing the overlying placenta which is often infarcted. 
For differentiation purpose, a simple adherent blood clot can be easily 
stripped from the maternal surface and never indents the placental 
substance. 
 
Microscopy : 
Early stages  : RPH  c/o solely RBCs and few strands of fibrin. 
As lesion ages  : RBCs degenerate  
    Amount of fibrin increases 
    Leucocyte and macrophage infiltration. 
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Later Stages  : hemoriderin laiden macrophages in basal plate. 
 
 In all, overlying basal plate may be normal or necrotic or may 
contain a heavy infiltration of polymorphonuclear leucocytes. 
 
C) Marginal hematoma 
 This is formed at the lateral margin of the placenta. This is referred 
as subchorionic hemorrhage by USG. 
 
Incidence : 
 Wilkin (1965) found marginal hematoma in 0.74% of placentas. 
 There seems to be no association with maternal preeclampsia.  
 
D) Intervillous thrombi: 
 These are villous free, nodular foci of coagulated blood in IVS. 
They however don’t fulfill the criteria for thrombus in that they lack 
platelets. Villi are absent from this thrombus. 
 
 Incidence varies from 3 - 50% in full term, uncomplicated 
pregnancies. It is increased in materno-fetal rhesus compatibility(120-122) 
 
E) Kline’s hemorrhage: 
 There are vague hemorrhagic areas in placental substance. Fox 
refers to this as a very fresh intervillous thrombus. 
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F) Subamniotic hematoma: 
 This refers to the accumulation of blood between the amnion & 
chorion on fetal surface. This is known to arise due to trauma to the 
venous tributaries of umbilical vein at the time of excessive traction. 
 
IV. Non Vascular lesion: 
Calcification: 
 The incidence of gross calcification in the placenta varies in 
various studies, from 14-37%(123-127). Schonig has conceded that two 
forms of calcification exist.(128) 
 
a) Physiologic – First 6 months -  not visible to naked eye. 
b) Dystrophic – Later pregnancy period – Grossly valuable. 
 
 Pathologist can identify only the second type of calcification. 
 
 Calcification is less common in placenta with less than 36 weeks 
gestational age and it increases as the term approaches. 
 
 Various studies have proved that gross placental calcification is of 
no pathological or clinical significance(125,127,129). There is no significant 
increase in calcification of placentas from prolonged 
pregnancies(125,130,131), Maternal pre eclampsia ,essential hypertension or 
diabetes mellitus (100,127) . 
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 Various studies have proposed that serum calcium level in the 
mother is a factor in the pathogenesis(133,134). But Tindall & Scott have 
indicated that further mechanism apart from maternal serum calcium 
level are involved. The occurrence of placental calcification has been 
associated with primigravidity(124,129) and also with high socio-economic 
status in community(131). 
 
Gross  
 Seen as small, hard, scattered flicks on the maternal surface, 
mainly seen in the basal plate and septa. It is unusual to see it in the 
chorionic plate. There can be calcium deposition in old infarcts and 
perivillous or subchorionic fibrin.  
 
Microscopy : 
 Seen as structureless, basophilic material deposited either as 
plaques or coarse granules. Calcification of villi may be seen at times. 
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DEFINITION AND CLASSIFICATION OF HYPERTENSIVE 
DISORDERS OF PREGNANCY(134,135) 
 Pre-eclampsia is a pregnancy specific syndrome characterized by 
elevation of blood pressure of more than 140mm of Hg systolic or more 
than 90mm of Hg diastolic with proteinuria after 20 weeks of gestation. 
 
 Eclampsia is defined as the occurrence of seizures in a women with 
preeclampsia, that cannot be attributed to other causes. 
 
 Multiple classifications have been proposed to classify the 
hypertensive disorders of pregnancy. The working group of National 
High Blood Pressure Education Programme (2000) recommended the 
following classification. 
 
GESTATIONAL HYPERTENSION: 
 BP > 140/90 mm of Hg for first time during pregnancy no 
proteinuria. 
 BP returns to normal <12 weeks post partum. 
 Final diagnosis made only post partum. 
 May have other signs of pre-eclampsia, for example, epigastric 
discomfort or thrombocytopenia. 
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PRE-ECLAMPSIA: 
Minimum criteria: 
 BP > 140/90 mm Hg after 20 weeks for gestation. 
 Proteinuria > 300mg/24 hours or > 1+dipstick 
 
Increased certinity of preeclampsia 
 BP > 160/110 mm of Hg. 
 Proteinuria 2.0g/24 hours or > 2 + dipstick 
 S.creatinine> 1.2 mg/dl unless known to be previously elevated 
 Platelet < 1,00,000/mm3 
 Microangiopathic hemolysis (increased LDH) 
 Elevated ALT or AST 
 Persistent headache or other cerebral or visual disturbance 
 Persistent epigastric pain. 
 
ECLAMPSIA: 
 Seizures that cannot be attributed to other causes in a woman with 
pre-eclampsia. 
 
Super imposed pre-eclampsia (on chronic hypertension) 
 New onset proteinuria >300mg/24 hours in hypertensive women 
but no proteinuria before 20 weeks gestation. 
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 A sudden increase in proteinuria or blood pressure or platelet count 
<1,00,000/mm3 in women with hypertension and proteinuria before 20 
weeks gestation. 
 
CHRONIC HYPERTENSION: 
 BP > 140/90 mm of Hg before pregnancy or diagnosed before 20 
weeks of gestation. 
 Hypertension first diagnosed after 20 weeks of gestation and 
persistent after 12 weeks post partum. 
 
Hypertensive disorders during pregnancy : Indicators of severity 
Abnormality Mild Severe 
Diastolic blood pressure <100 mmHg 110mm Hg or higher 
Proteinuria Trace to 1+ Persistent 2+ or more 
Headache Absent Present 
Visual disturbance Absent Present 
Upper abdominal pain Absent Present 
Oliguria Absent Present 
Convulsion Absent Present 
Serum Creatinine Normal Eclampsia elevated 
Thrombocytopenia Absent Present 
Liver enzyme elevation Minimal Marked 
Fetal growth restriction Absent Obvious 
Pulmonary oedema Absent Present 
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WHO Classification(136): 
 Uses the limit of 90 mmHg diastolic blood pressure, but specifies 
that woman should be normotensive before 20th week of pregnancy. 
 
 In a previously hypertensive woman, pre-eclampsia is diagnosed if 
there is an increment of 15mm of Hgt in diastolic pressure and/or 
development of proteinuria. 
 
 A diastolic pressure of 90mmHg, but measured twice at least 4 
hours apart, diminishing the influence of “white coat hypertension”. 
 
 A diastolic pressure of 110mmHg is sufficient for the diagnosis if 
measured only once. 
 
RISK FACTORS FOR PRE-ECLAMPSIA(137,138) 
Pre-conceptional and/or chronic risk factors: 
Partner related risk factors 
 Nulliparity / primipaternity / teenage pregnancy 
 Limited sperm exposure, donor insemination oocyte donation 
 Partner who fathered a pre-eclampsia pregnancy in another woman. 
Non partner related risk factors 
 History of previous pre eclampsia 
 Age, interval between pregnancies 
 Family history 
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Presence of specific underlying disorders 
 Chronic hypertension and renal disease, obesity, insulin resistance, 
low birth weight gestational diabetes, type I diabetes mellitus. 
 Activated protein C resistance, protein S deficiency. 
 Antiphospholipid antibodies. 
 Hyper homocysteinemia 
 Sickle cell disease, sickle cell trait 
 
ETIOLOGY AND PATHOPHYSIOLOGY OF  
PRE-ECLAMPSIA(135,139-148) 
 The cause of pre-eclampsia is not known. Many consider the 
placenta the pathogenic focus for all manifestations of pre-eclampsia 
because delivery is the only definitive cure for this disease. 
 
 The four main etiological factors believed be involved in 
development of pre eclampsia are; 
 
1) PLACENTAL ISCHAEMIA HYPOTHESIS: 
 Reduced placental perfusion plays a major role in pregnancies 
complicated by pre-eclampsia. 
 
 In normal pregnancy due to the trophoblastic invasion, the diameter 
of the spiral arteries proximal to the trumpet shape outlet increases 4-6 
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fold, relative to that of non pregnant women. The endothelium is replaced 
by trophoblast and the internal elastic lamina is replaced by trophoblast 
and an amorphous matrix that predominantly consists of fibrin deposits. 
These vascular changes extends from the intervillous space upto the inner 
third of the myometrium. By contrast these changes develop defectively 
in pre-eclamptic  women and are also limited to the decidual portion of 
the spiral arteries, the myometrial segment maintaining the smooth 
muscle layer. 
 
 The consequence of this abnormal invasion of the spiral arteries is 
the deficient uteroplacental circulation already at the end of first 
trimester. 
 
 The placental under perfusion results in the release of various 
toxins into the circulation, such as oxygen free radicals and lipid 
peroxides, causing oxidative stress or impaired antioxidant defenses, 
activation of leucocytes, and release of cytokines. The result is 
widespread endothelial dysfunction and cellular activation. 
 
2) OXIDATIVE STRESS THEORY: 
 Activated / injured endothelial cells, release procoagulants, 
vasoconstrictors, and mitogens that promote platelet agglutination and 
activate coagulation cascade. 
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Role of oxidative stress: 
Oxidative process has been proposed to play an important role in 
the etiology of uteroplacental vascular endothelial damage in 
hypertensive disorders of pregnancy. Oxidative processes such as lipid 
peroxidation, the conversion of unsaturated fatty acids by free radicals to 
lipid peroxides, occur normally at low levels in all cells and tissues. 
Control of the potentially self perpetuating lipid peroxidation chain is 
regulated through anti-oxidant systems such as vitamin E and selenium. 
An imbalance between oxidative and antioxidative system leads to a 
steady state with high levels of free reactive oxygen species and lipid 
peroxides; this imbalance is termed oxidative stress. It causes disruptive 
membrane damage in endothelium. 
 
 Markers of oxidative stress such as glutathion peroxidase and 
malondialdehyde are increased. Additional evidence is given by the 
elevated levels of cytokines such as TNF-alpha and intcrleukines. These 
cytokines are strong initiators of oxidative processes.  
 
3) IMMUNE MALADAPTATION HYPOTHESIS: 
• Pre-eclampsia may result from an abnormal maternal immune 
response to paternally derived antigens on the trophoblast. 
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• It is postulated that activated immune cells from decidua release 
mediators like plasma elastase, toxic proteases and cytokine like 
TNF-alpha, IL-1, IL-6 which cause endothelial damage. 
• Elastase - destroys the integrity of endothelium. 
 
TNF-alpha, IL-1 : 
 Increased generation of thrombin, platelet activating factor, 
endothelial cell permeability, increased expression of ICAM-1,VCAM-
1(which mediate adherence of inflammatory cells and activate endothelial 
cells). 
 
IL-6 : 
 Increases vascular permeability, stimulate platelet derived growth 
factor synthesis, impairment of PGI2 synthesis. 
 
 Lipid peroxides formed as a result of increased oxidative stress 
inhibit PGI2 synthesis, favours production of platelet derived 
thromboxane A2 (TXA2), alters  the capillary permeability to proteins 
and triggers thrombosis formation. 
 
 This leads to generalized vasospasm, oedema, and proteinuria 
and thrombus formation. 
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4) PREECLAMPSIA AS A GENETIC DISEASE : 
Genetic predisposition could be involved in 
a) Any aspect of pre-eclampsia etiology : 
Immune maladaptation/ placental ischaemia/ oxidative stress. 
b) Genes involved in blood pressure regulation/ placentation / vascular 
injury / remodeling etc. 
eg:     Ag-1 gene (angiotensiongen gene) 
E-Nosgene (endothelial nitric oxide synthetase gene) 
ET-1 gene (endothelin - 1 gene) 
 
 HLA's are involved in immune tolerance and thus deviation from 
normal expression plays a role in immune maladaptation. 
 
PATHOLOGY OF PLACENTA IN PRE-ECLAMPSIA 
Placenta from preeclamptic women tend, on average to be smaller 
than those from uncomplicated pregnancies. But, the decrease is only 
slight and a proportion of such placentae are unusually large. 
 
The various morphometric parameters like weight, volume, surface 
area have been shown in a number of studies to be significantly lower in 
hypertensive pregnancies than normal term pregnancies. 
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As far as macroscopic features are concerned, there is no 
significant increase in the incidence of extrachorial placentation or of 
abnormal cord insertion in preeclamptic placentae. 
 
The only two gross lesions that are significant in preeclamptic 
placentae are; 
- Infarction 
- Retroplacental hematomas 
 
Infarction: 
 The incidence of placental infarction ranges from about 33% in 
cases of mild preeclampsia to approximately 60% in patients with severe 
form of the disease. (149) 
 
 Extensive infarction (involving more than 10% of parenchyma) is 
found in about 30% of placentae from cases of severe preeclampsia, but 
not a feature of the milder forms of this disease(149). 
 
Infarction is the dramatic and easily recognized visible sign of 
maternal uteroplacental vascular unsufficiency. Infarcts are more 
significant when they are central and greater than 3 cm in greatest 
dimensions. Infarction is associated with significant perinatal mortality 
and  morbidity,  including IUD , fetal hypoxia and  neonatal  mortality 
and morbidity.  
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 Thus, extensive infarction occurs only against a background of 
markedly abnormal maternal vasculature and a restricted maternal blood 
flow to the placenta and  it is these factors rather than the loss of villi due 
to infarction which are the real cause of the fetal complications. The true 
significance of extensive placental infarction is therefore that it is the 
visibile hallmark of a severely compromised circulation to the placenta. 
 
Retroplacental hematoma (RPH) 
 Retro placental hematomas are found unduly frequently in 
preeclamptic placenta occurring in about 12-15% of all cases.  
 
 There is a majority of opinion saying, this hemorrhage is a result of 
rupture of a maternal decidual arteriole, which is believed to be a 
catastrophe occurring in the vessel wall that has been weakened due to 
changes in preeclampsia.(150-156)  
 
 Initially abruption was considered specific and integral part of 
preeclamptic  process(157,158). In support of this, in various reviews on 
abruption, there was a high percentage of patients affected by 
preeclampsia(159-162). However in some reviews on abruption, the 
percentage of preclamptic patients has been on a lower level(163,164).  
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 Williams et al (1991b) in his study(165), concluded that though there 
was  a high risk of placental abruption  with essential hypertension, this 
was certainly not the case with preeclampsia. This fell in accordance with 
the study of Abdella et al (1934) who found that the incidence of 
abruption  in patients with preeclampsia was 2.5% , while in those  with 
essential  hypertension was 10% .And the highest incidence was in 
women with eclampsia, ie.23.6%(166).  
 
 So, it would be fair to say that the pregnancy of RPH is increased 
in preeclamptic placentae.  
 
 Large lesions where in 40% or more of villous population is 
acutely deprived of blood supply are associated with high incidence of 
fetal hypoxia, death.  
 
 Subamniotic hematoma, marginal hematoma, massive sub chorial 
thrombosis intervillous thrombosis are of not much clinical significance.  
 
 Placental calcification, often regarded as evidence of either 
placental senescence or degeneration and of no pathological or clinical 
significance and not associated with  any fetal complication.  
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Histological findings : 
 As per fox, villi of most preclamptic placentas have normal 
maturity for that gestational period. However in a few cases, there is 
notable delay in villous maturation and it was found that this was by large 
restricted to severely preeclamptic pregnancies with resultant severe 
growth retarded fetus(167,168). Still on the contrary some preeclamptic 
placenta showed evidence of accelerated villous maturation as per Fox. 
 
 The most characteristic and striking features of villi in pre-
eclampsia are 
- Undue number as well as prominence of villous CT cells.  
- Irregular thickening of trophoblastic basement membrane and 
this can best be appreciated when stained with PAS. 
- The intensity of these changes correlate with duration and 
severity of maternal preeclampsia.  
- Occasional villi with a thickened TBM are found in about 1/3rd 
fetal placenta.  
 
 A striking increase in the proportion of villi with unduly thick 
TBM is common feature in preeclamptic placenta. Fetuses whose 
placenta contain a marked excess of villi with abnormally thick TBM 
have a much higher incidence of clinical hypoxia than do those in which 
the changes are absent. However, various studies say that the high 
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incidence of fetal hypoxia found in association with this abnormally is 
due, not to basement membrane changes, but to the ischemia which is 
responsible both for the histologic changes and fetal complications.  
 
 The vascularisation of the villi is often normal but a significant 
percentage of placental villi are hypovascular. They contain relatively 
inconspicuous, non-dilated, small vessels. This particular change 
correlates with the level of obliterative endarteritis of fetal stem 
arteries(169,170), which is found in around one third of preeclamptic 
placentae. 
 
 These hypovascular villi which are inadequately perfused from 
fetal side show.  
 Abundant syncytial knotting 
 Lack VSM 
 Increased amount of stromal collagen.  
 
 The hypoxic placenta in  preeclampsia is composed of numerous 
branched, short  and fist like appearance of terminal villi. This greatly 
enhances the degree of syncytial knotting (flat sections), that a net like 
appearance may be discovered in the two dimensional picture.  
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Villous edema 
 It has been widely appreciated that villous edema may also be 
found in placenta from women with preeclampsia.  
 
 The cause of villous edema is unknown, it has been attributed to 
functional insufficiency of fetal circulation, increased size of the 
edematous villi may decrease the capacity of IVS and thus limit the 
maternal flow through the placenta.  
 
Fibrinoid degeneration of villi : 
 The first stage in the evolution of this lesion in the appearance of a 
small nodule of homogenous, acidophulic, PAS positive material at one 
point in the villious trophoblast. This nodule progressively enlarges as 
fresh fibrinoid material is laid down on its deep aspect so as to form a 
mass which gradually bulges into and compresses the villous stroma, this 
process continuing until the whole villous is converted into a fibrinoid 
nodule.  
 
 The incidence of villous fibrinoid necrosis is found to be 
moderately increased in preeclamptic placentas.  
 
 The lesion has been attributed to an immunological reaction within  
villous tissue and to amyloid deposition as an ageing change. 
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 The pathologist  noting an excess of villi showing fibrinoid 
necrosis in a placenta is therefore not, at the moment in a position to 
arrive at any valid conclusion from this finding, though the possibility 
that it represents an immune attack on trophoblastic tissue cannot be 
totally discarded and should be borne in mind.  
 
PATHOGENESIS OF MORPHOLOGIC CHANGES  
 As agreed by most of them,  all of the changes in preclamptic 
placentae except VFN are a consequence of abnormal maternal 
uteroplacental vasculaure . This fact of reduced blood flow has been well 
established over many years(171-174) .  
 
 This has also been confirmed with Doppler studies(175-180). It is a 
well known fact that this uteroplacental insufficiency is a result of 
incomplete trophoblastic invasion of placental bed spiral arteries and thus 
the spiral arteries are inadequately converted to uteroplacental vessels.  
 
 The increase in incidence of placental infarction in preeclampsia is 
attributed to atherosis in  spiral arteries.  
 
 Cytotrophoblastic hyperplasia is a specific response and TBM 
thickening a non specific response to placental ischemia. Thus these are 
direct effects of reduced maternal blood flow.  
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 The excess of syncytial knots and villous stromal fibrosis are a 
result of reduced villous perfusion due to obliterative endarteritis of fetal 
stem vessels, which is a hallmark for prolonged vasoconstriction of these 
stem vessels. This leads to rise in placental vascular resistance(181). All 
this represents the fetal hemodynamic response to uteroplacental 
ischemia(182-189). This reduction in placental fetal perfusion is in fact a 
compensatory mechanism by which there is preferential diversion of 
blood to the vital cerebral and cardiac circulation of fetus.  
 
 Itskovitz et al considered that the villous tissue can enhance oxygen 
extraction in the face of decreased blood flow and can withstand a 
reduction of 50% blood flow without having any adverse effect on fetal 
oxygenation(190).  
 
FETUS IN PRE ECLAMPSIA 
 Fetal growth restriction (FGR) is the end point of a number of 
pregnancy associated conditions and pre-eclampsia(PE) is one of them. 
PE is regarded as a syndrome of heterogeneous origin and fetal growth is 
very often restricted in it. Preeclampsia with shallow trophoblastic 
invasion of decidual arteries, reduce placental perfusion and cause 
insufficient transport of nutrients to fetus. Placental morphologic changes 
vary substantially in PE and it has been hypothesized that FGR depends 
on abnormal placental development. Pathophysiological process of FGR 
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and the responses of fetus to the restricted nutrition and oxygen supply 
are very complex and far from fully understood.. 
 
 Odegard et al in 2000 made a study and reported the following 
observations that PE was associated with a 5% reduction in birth weight. 
In severe PE, the reduction was 12% and in early onset disease, birth 
weight was 23% lower than expected. The risk of SGA was four times 
higher in infants bom to women with PE among nullipara, PE associated 
with threefold higher risk of SGA and among parous, the risk of SGA 
was particularly high after recurrent PE. They concluded that factors like 
multiparity, severity of disease (mild, moderate and severe) and late 
versus early onset disease play a synergistic role in FGR in PE. Though 
the possibility that it represents an immune attack on trophoblastic tissue 
cannot be totally discarded and should be borne in mind(191) .  
 
  
Materials and Methods 
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MATERIALS AND METHODS 
 
Study Design  : Prospective Study. 
Study period   : June 2014 to December 2014 
Study Place  : Institute of Obstetrics and Gynaecology,  
    Madras Medical College, Chennai-3 
Sample size : 
Study group  : 100 cases 
Control group  :  100cases 
 
Inclusion criteria 
Study Group : 
1. Singleton pregnancy 
2. Pre-eclampsia BP>140/90 ; Urine albumin + 
3. Eclampsia 
Control Group: 
1. Singleton pregnancy 
2. Normotensive 
 
Exclusion criteria 
1. Women  with multiple pregnancy 
2. Women with pre existing hypertension 
3. Preeclampsia with comorbid conditions 
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METHODOLOGY 
 Detailed history of the mother such as name, age, parity, address, 
occupation, marital history, previous obstetric history, past history of 
major illness, present medical history and habits were recorded on 
predesigned  proforma with regard to  the baby’s  gestational age. Birth 
weight and Apgar scores were observed from the record. 
 
 All placentas were collected immediately after delivery and washed 
in tap water which removed the blood collected in membranes and clots. 
 
Grossing procedure 
 Placenta was examined in fresh state after delivery, handling the 
specimen with great care avoiding lacerations. 
 
Membranes: 
 Distance from the placental margin to the nearest point of rupture 
was measured. Membranes were examined for completeness, insertion, 
decidual necrosis, edema, extra-amniotic pregnancy, retromembranous 
hemorrhage, meconium staining, colour and transparency. A long 2-3cm 
wide section of membranes beginning with the point of rupture and 
extending to and including a small portion of placental margin were taken 
and rolled with amniotic surface inward, fixed for 24 hours and 3mm 
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section was taken from the centre. Trim the remaining membranes from 
the placental margin 
 
Umbilical cord: 
 The length of the cord and the shortest distance from the cord 
insertion to the placental margin were measured. Cord was examined for 
insertion, number of umbilical vessels, colour, true knots, torsion, 
stricture, hematoma and thrombosis. Cord was removed from the placenta 
3cm proximal to the insertion ,  2-4cm segment from its midpoint was 
taken, fixed for 24hours and 3mm section was taken. 
 
 The disc weight should be obtained once the membranes, cord, and 
extraeneous clot have been removed. A major variable in placental 
weight is the amount of fetal blood  present in the placenta. 
 
 Measurements of the generally ovoid disc should be taken along 
the greatest and shortest diameter. The thickness is best measured after 
cutting . 
 
 With these basic measurements, using standard mathematical 
formulae, the values for placental surface area and placental volume were 
derived. 
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 Placental surface area (cm2 ) = (π x largest diameter x shortest 
diameter )/ 4 
 
 Placental volume (cm3)  =  surface area x thickness at centre 
 
 The placenta along with cord and membranes will be coded and 
preserved in 10% formalin . 
 
Fetal surface: 
 Examination for colour, opacity, subchorionic fibrin, cysts, amnion 
nodosum, squamous metaplasia, thrombosis of fetal  surface vessels and 
chorangioma was done. 
 
Maternal surface: 
 Examination for completeness, normal fissures, laceration, 
depressed areas, retroplacental hemorrhage was done. 
 
 The parenchyma should be sectioned in a “bread –loaf fashion” at 
approximately 1 to 2 cms interval, cutting with either the fetal or maternal 
side down. The cut slices should be examined for the presence of focal 
lesions such as infarcts , thrombi , and , excessive fibrin. 
 
 Sections of the villous parenchyma should be taken to include the 
full thickness of the placenta, extending from the maternal to fetal 
surface, including both amnion and decidua. 
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- The placental changes were compared in the two groups. 
- Placental changes were correlated with duration and severity of 
peeclampsia. 
- Placental findings were correlated with fetal outcome. 
 
STATISTICAL ANALYSIS : 
 Comparision of various parameters between the study groups will 
be analysed by ANOVA and by student’s  “t” test. 
 
 Categorical data will be analysed by Chi-square test. 
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TABLE 3 :     COMPARISION OF PLACENTAL 
MORPHOMETRY 
 
 
CASE 
(mean ± S.D) 
CONTROLE 
(mean ± S.D) 
p - 
Value 
Placental Weight 
(gms) 421.8±120.09 461.75±99.08 0.011 
Placental Surface Area 
(sq.cm) 172.77±60.82 195.25±58.82 0.009 
Placental Volume 
(cu.cm) 270.8±132 385.01±142.66 0.001 
 
 The mean placental weight is reduced in preeclampsia. This is 
statistically significant. 
 
 The mean placental surface area is reduced in the preeclamptic 
group and is statistically significant. 
  
 The mean placental volume is again decreased in the preeclamptic 
group when compared with the control group. This is also statistically 
very significant. 
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The incidence of retroplacental hematoma and infarction is 
significantly raised in the study group in comparison to control group. 
But, there is no significant difference in the occurrence of sub chorionic 
fibrin and calcification between the two groups. 
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TABLE 5 :  COMPARISION OF PLACENTAL 
HISTOMORPHOLOGY 
5 (A) 
PLACENTAL 
HISTOMORPHOLOGY
GROUP 
p 
VALUE 
CASE CONTROL 
Mean ±S.D Mean ± S.D 
Mean no of areas of 
Syncytial knot formation/ 
LPF 
23.15 ± 4.84 9.75 ± 3.18 < 0.001 
Mean no of areas of 
Cytotrophoblastic cellular 
proliferation / LPF 
17.72 ± 2.63 5.78 ± 1.31 < 0.001 
Mean no of areas of 
villous Fibrinoid 
degeneration /LPF 
7.05 ± 2.87 3.04 ± 1.24 < 0.001 
Mean no of areas of 
villous Stromal fibrosis/ 
LPF 
9.22 ± 2.19 2.47 ± 1.01 < 0.001 
 
 In the preeclamptic group, there is an increase in the mean no. of 
areas / lpf of syncytial knot formation , cytotrophoblastic cellular 
proliferation , villous fibrinoid degeneration  & villous stromal fibrosis. 
This difference is statistically significant. 
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TABLE 7: CORRELATION OF PLACENTAL 
HISTOMORPHOLOGY WITH SEVERITY OF PREECLAMPSIA 
IN STUDY GROUP 
 
 SK / LPF CT prolif / LPF VFD / LPF VSF / LPF 
DIASTOLIC 
BP +0.642 +0.471 +0.510 +0.505 
 
 In this study, there is a positive correlation  between the severity of 
preeclampsia and histomorphologic  features.  ie. With an increase in the 
severity of preeclampsia , there is statistically significant increase in the 
mean number of areas of syncytial knot formation / lpf , cytotrophoblastic 
cellular proliferation / lpf , villous fibrinoid degeneration / lpf and  villous 
stromal fibrosis / lpf  . 
 
TABLE 8 :  CORRELATION OF PLACENTAL MORPHOMETRY 
WITH HISTOMORPHOLOGY IN THE STUDY GROUP 
 SK / LPF CT prolif / LPF VFD / LPF VSF / LPF 
Placental 
Weight - 0.137 - 0.111 - 0.225 - 0.151 
Placental 
Surface Area - 0.141 - 0.013 - 0.211 - 0.117 
Placental 
Volume - 0.215 - 0.082 - 0.331 - 0.157 
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 In this study, there is a negative correlation between placental 
morphometry and intensity of microscopic changes, ie. With a decrease in 
the morphometric values , there is an increase in the extent of 
microscopic changes . 
 
TABLE 9: CORRELATION OF PLACENTAL MORPHOMETRY 
WITH FETAL OUTCOME 
 
 FETAL BIRTH WEIGHT APGAR 
Placental Weight + 0.841 + 0.668 
Placental Surface Area + 0.536 + 0.488 
Placental Volume + 0.574 + 0.435 
 
 In this study,  there is a highly significant  positive correlation 
between placental morphometry and fetal outcome , ie. With a decrease 
in placental morphometric values , the fetal outcome will be adversely 
affected.  
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DISCUSSION 
 
Preeclampsia is one of the leading causes of maternal as well as 
perinatal mortality and morbidity. The etio-pathogenesis of preeclampsia 
still remains a subject of controversy. The classical view in this regard 
focuses on the placenta and uteroplacental circulation. 
 
 Pregnancy induced hypertension clinically presents with 
hypertension, proteinuria and edema. Typically once the uterus is emptied 
of the fetus & the placenta, the disease process ceases . Infact immediate 
post partum curettage of the placental bed, brings down the maternal 
blood pressure at a faster pace than in places where curettage is not done. 
The fact that PIH occurs even in the absence of the fetus, for eg . in 
hydatidiform moles , shows clearly that PIH is ultimately dependent on 
the presence of placental tissue. 
 
 Although the study of placenta is retrospective in nature, yet it 
provides a reflection of hazards, the fetus has been subjected to, during its 
growth and development. 
 
 In the earlier studies of the effect of maternal disease on placenta, 
gross abnormalities have received undue attention. It is difficult to define 
the normal placental findings and differentiate it from the abnormal, 
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because of the structural complexity and rapid evolution of the placenta. 
Fox (1978 ) suggested that placental pathology is quantitative rather than 
qualitative(192). Bernischke and kaufman (2000) stressed the significance 
of placental findings only when these had a bearing on the fetal 
outcome(7). 
 
Fetal outcome : 
 Fetal and placental growth restriction are frequently encountered 
manifestations of preeclampsia. The correlation of various placental 
findings with fetal outcome measured in terms of birth weight and 
APGAR  will be dealt in the following discussion. Apart from growth 
restriction , there are many sporadic reports of thrombocytopenia and 
other hematological disorders in babies of preeclamptic mothers(193,194) . 
 
Fetal birth weight : 
 This study shows fetal weight is significantly reduced in the 
hypertensive group than in the control group .These findings corroborate 
with studies of other workers Damania( 1989 ), Fox (1994 ), Kalousek 
(1994 ), Pradeep S Londhe(2011)195-198 . Rath in 1994 quoted that the 
intercotyledonous vasculature is altered, ending in low birth weight of 
infants(199). 
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 As per this study , with increasing severity of preeclampsia , there 
is corresponding decrease in the fetal birth weight. 
 
PLACENTAL MORPHOMETRY 
Placental weight : 
 Normally, a placenta weighs from 400 to 800 gms . This study 
observed the reduction of placental weight in the preeclamptic group . 
Similar findings were reported by Bandana Das et al(1996), Dutta (1989), 
and Nobi’s Das(1991), Pradeep S Londhe(2011)(198,200-202).   
 
 The decrease in placental weight has a significant negative 
correlation with increasing severity of preeclampsia and the extent of 
morphologic changes. Similar results were obtained by Majumdar et al   
in his study(203) . 
 
Placental surface area : 
 The mean placental surface area is significantly decreased in 
preeclamptic placentae. This is in concordance with the study of Pradeep 
et al and Majumder et al(198,203). In a recent study by Rath et al (2000)(199), 
the mean placental surface area in preeclamptic group was 209.36 cm2 
and that in the control group is 254.63 cm2  .  
 
 This finding also has a significant negative correlation with 
increasing severity of preeclampsia and a significant positive correlation 
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with fetal outcome . Similar results were obtained by Majumder et al, 
Bandana Das and Kaizad et al200,203,204) . 
 
Feto-placental ratio : 
 At  term , the feto-placental ratio varies between 6:1 and 8:1. The 
present study noted that there was a reduction in feto-placental weight 
ratio in the preeclamptic group compared to normotensive group. Similar 
results were obtained by Bandana Das(1996) and Kher zawar 
(1981)(200,205).  These findings also corroborate with the findings of 
Thompson et al, Nummi,  and Soma(206-208. 
 
PLACENTAL GROSS MORPHOLOGY: 
Sub chorionic fibrin : 
 Sub chorionic fibrin was not found to be increased in this study. 
Most of the studies (Fox 1967, Mallik et al 1979 ) did not record the 
increased incidence of sub chorionic fibrin in preeclamptic placentae 
(149,209).However, Bandana Das (1996) noted an increase in the incidence 
of sub-chorionic fibrin, but still it did not have any effect on the fetal 
outcome.(200) 
 
 Sub chorionic fibrin plaques are not of any clinical significance and 
does not interfere with fetal growth or development(149) 
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Retro-placental Hematoma : 
 This study showed a highly significant increase in the incidence of 
retro placental hematoma in preeclamptic pregnancies when compared to 
the control group. 
 
 In most reviews, by Fox (1978 ) and Mohan et al (1989), Daro et 
al, Bevis, Vermelin & Braye and Hsu et al, they have reported that a high 
proportion of placentae with retro-placental hematoma belonged to the 
preeclamptic group.(159-162,192,210) . 
 
 Whether a RPH has a significant effect on the fetus mainly depends 
on the size. Small lesions are insignificant .  Where as large hematomas, 
lead to extensive areas of infarction by creating a plane of separation 
between maternal blood vessels and a proportion of overlying villi. Thus 
the important and functionally significant lesion is the resultant infarct 
rather than the hematoma. When such a lesion involves more than 40% of 
maternal surface , a significant proportion of the villi are deprived of their 
oxygen supply with an adverse impact on fetal outcome. 
 
 Tatum (1953), Dyer & Mc Caughey (1959), Hibbard & Hibbard 
(1963) emphasized the fact that abruption / RPH is not diagnostic of 
preeclampsia  as was earlier believed(211-213) . 
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Infarction : 
 In this study , there was a definite increase in the incidence of 
infarction in the preeclamptic group and the incidence increases with 
increasing severity of the disease. Similar findings were observed by Fox 
(1967 b), Bandana Das et al, Wallenburg (1969), Budliger (1964) 
(149,200,214,15). The incidence of infarction in the control group was 5%.  
 
 Wentworth (1967), in his study showed that there was a significant 
increase in incidence of infarcts (67%) in severely toxemic patients , 
where as mildly toxemic patients had only 11.7% incidence of 
infarcts(216). Fox(1967) and Udania et al (2004) had observed a similar 
raise in the incidence of placental infarction with severity of 
toxemia.(149,217) 
 
 Fox says , extensive infarction , ie. Infarction involving more than 
5% of placental tissue occurs in 30% of placentae from severe 
preeclamptic patients , where as it is present in only 2% of mild 
preeclamptic placentae(149).  
 
 According to the work of Kloosterman & Huidekoper (1952, 
1954), Little (1960), and Wigglesworth(1964) there can be no doubt  that 
commonly occurring minor degree of placental infarction (which involves 
less than 5% of parenchyma ) is of no clinical significance. But extensive 
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placental infarction is associated with a high incidence of fetal hypoxia , 
IUGR & death(218-221).  
 
 Richard Naeye(1977) deduced in his study , that placental 
infarction caused 2.26/1000 perinatal deaths and that fatal infarcts were 
strongly associated with diastolic pressures over 90 mmHg in the 
gravid(222). 
 
 Wallenburg (1969) noted a significant correlation of infarction with 
low APGAR score and low birth weight(214). 
 
Calcification : 
 The incidence of calcification was 17%  in cases and 15%  in 
control groups. This is not statistically significant . Similar findings were 
given by Fox (1966a) ,Brandt (1973). (100,127) 
 
 The view that calcification is a hallmark of placental senescence or 
degeneration is no longer tenable . various studies have associated 
calcification with primigravidity(124,125,127,129,223) , young age , higher 
socio-economic groups(131) and maternal serum calcium levels (132,133). 
 
PLACENTAL HISTOMORPHOLOGY 
 The histology of placenta from preeclamptic pregnancies shows a 
significant increase in villous cytotrophoblastic proliferation, villous 
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syncytial knot formation , irregular thickening of trophoblastic basement 
membrane, patchy villous fibrinoid degeneration and villous stromal 
fibrosis, in the study group when compared to the control group. 
 
 This is very much in accordance with previous studies conducted 
by Jones & Fox(1980). Genset (1992) reported that stromal fibrosis and 
excessive syncytial knot formation are seen in generalized form , 
occurring due to overall reduction of fetal perfusion of placenta.(224,225) 
 
 Teasdale (1980) and Udainia et al (2004) quoted that localized 
villous fibrinoid degeneration could be the aftermath of 
hypertension.(217,226) 
 Tenny & Parker (1940) quoted that the influence of maternal 
factors is best shown in preeclampsia where the decreased intervillous 
blood flow finally leads to increased  syncytial knotting, so called the  
Tenny- Parker changes. He emphasized that the increased bridging of 
placental syncytium producing knots, is very much characteristic of 
preeclampsia. Syncytial knots are also seen normally in term and preterm 
placentae but there number is much increased in toxemia.(227) 
 
 Mohan Harsh et al (1989) analysed the macroscopic lesions and 
villous alterations seen in placentae of toxemia of pregnancy and 
correlated with fetal outcome(210). It was observed that lighter placentae 
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were associated with low birth weight new borns. The most striking 
villous lesions seen in placenta were cytotrophoblastic cellular 
proliferation , thickening of trophoblastic basement membrane and these 
lesions were associated with fetal complications like low birth weight, 
birth asphyxia and still birth. Similar findings were reported by Kher.AV. 
Zauer(1918) and Kalra VB et al (1985)(205,228) 
 
  
Summary 
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SUMMARY 
 
The observations noted in the present study are : 
1. More number of preterm delivered cases belonged to preeclamptic 
group. 
2. Fetal birth weight was  significantly reduced in preeclamptic group. 
3. The placental morphometry , ie. Placental weight , surface area and 
volume was significantly decreased in preeclamptic group. 
4. There was a net reduction in feto-placental ratio in preeclamptic 
group . 
5. Incidence of sub chorionic fibrin was not increased in preeclamptic 
group 
6. Significant increase in the  incidence of retro placental hematoma 
was noted in the preeclamptic group. 
7. Incidence of still birth was increased in the presence of retro-
placental hematoma. 
8. Significant increase in the incidence of infarction was noted in the 
preeclamptic group. 
9. Presence of infarction was associated with poor fetal outcome. 
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10.  There was no significant increase in the incidence of calcification 
in the preeclamptic group. 
11. There was a significant increase in the mean  number of areas /lpf 
of the following findings in the preeclamptic group . And these also 
showed an increase in the intensity with increasing severity of 
preeclampsia.                                                                                 
 Villous  syncytial knotting / lpf 
 Villous  cytotrophoblastic cellular proliferation/ lpf 
 Irregular thickening of trophoblastic basement membrane 
(>3%) 
 Villous fibrinoid degeneration / lpf 
 Villous stromal fibrosis / lpf 
12.  There was a significant negative correlation between severity of 
preeclampsia and placental morphometry, ie. With increasing 
severity, there was a decrease in the values of placental weight , 
volume and surface area. 
13. This study showed a significant positive correlation between the 
severity of preeclampsia and the gross findings of RPH & 
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infarction, ie. With increasing severity of preeclampsia, there is an 
increase in the incidence of these values . 
14.  This study showed a significant negative correlation between 
placental morphometry and placental histomorphology in the 
preeclamptic group, ie. With decrease in morphometric values , 
there was an increase in the intensity of microscopic features .  
15.  Ultimately , this study revealed a significant positive correlation 
between placental morphometry and fetal outcome in the 
preeclamptic group, ie. The placentae with decreased morphometric 
values produced fetuses with low birth weight and a considerable 
decrease in the APGAR score. 
 
  
Conclusion 
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CONCLUSION 
 
 From  the present study , it can be concluded that although placenta 
readily adapts to hypoxia due to uteroplacental insufficiency , the 
compensatory changes are insufficient and result in a primary failure to 
develop and form an adequate placental mass, thereby adversely 
influencing the placental morphometry , gross and histomorphology. 
 
 The pathologic changes, including the placental morphometry and 
in particular,  retroplacental hematoma and infarction adversely influence 
the perinatal outcome. 
 
 Although there are various combinations of histologic and gross 
changes which are characteristic of placenta in preeclampsia , there is no 
single lesion which is invariably found in such placenta and none of the 
abnormalities are specific to preeclamptic placentae. 
 
 There are numerous cases where the preeclamptic placenta is 
virtually normal, mainly if the disease was mild and of a shorter duration. 
In severe preeclampsia, the lesions are however more prominent and 
accentuated and at the same time the duration of the disease is of 
importance. 
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 This study greatly emphasizes the importance of placental 
morphometry and its correlation with fetal outcome.  Currently , with the 
help of three dimensional ultrasonography and Virtual Organ Computer – 
Aided Analysis (VOCAL ), the placental volume can be ascertained  in 
utero and a correlation with the fetal growth can be obtained.  
 
 Thus , based on this study, a suggestion can be made  that in-utero 
measurement of placental volume be included in the routine monitoring 
of fetal well being in preeclamptic  pregnancies, thereby paving way for 
better management of at risk fetus. 
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Annexures 
ANNEXURE I 
DISSERTATION PROFORMA 
 
I) CLINICAL HISTORY 
Name :  
Age :                                                            IP No : 
Maternal gravidity/ parity /live /abortions : 
Gestational age : 
Blood pressure : 
H/O previous child birth : 
Any other relevant information : 
 
II) INVESTIGATIONS : 
Blood sugar : 
Blood urea / serum creatinine : 
Hemoglobin : 
Urine for albumin & pus cells : 
 
MODE OF DELIVERY :  
III ) NEWBORN DETAILS : 
Birth weight of baby : 
APGAR score : 
Any congenital anomalies : 
 
IV ) PLACENTAL WORKSHEET : 
A) MORPHOMETRY : 
1. Umbilical cord : 
 Cord insertion from margin (cm) 
 Cord length (cm) 
 No. of cord twists in 5cm  
2. Placenta : 
 Trimmed placental weight (gm) 
 Placental diameter ( greatest / smallest ) 
 Placental central thickness 
 Placental volume (cc) 
 Placental surface area 
 Feto-placental ratio 
B) GROSS EXAMINATION : 
1.Umbilical cord : 
 Cord colour 
 No. of vessels 
 Other cord findings 
 
2.Membranes  : 
 Membrane colour 
 Other findings 
 
3.Placenta : 
 Marginal vein for any thrombus 
 Fetal surface findings 
 Maternal surface findings 
 Parenchyma 
 Presence of infarction 
 Presence of calcification 
 
C) MICROSCOPIC EXAMINATION : 
 Villous cytotrophoblastic proliferation 
 Thickening of trophoblastic basement membrane 
 Syncytial knotting 
 Villous edema 
 Villous fibrinoid necrosis 
 Villous stromal fibrosis 
 
  
 ANNEXURE II 
INDICATIONS FOR PLACENTAL EXAMINATION 
Pediatric 
 Prematurity/postdates  
 Growth indices: intrauterine growth restriction/macrosomia 
 Unexpected adverse outcome  
 Congenital anomalies 
 Suspicion of fetal infection 
 Fetal hydrops 
 Fetal hematologic abnormalities 
 
 Obstetric  
 Stillbirth (important site to obtain tissue for culture for karyotype) 
 Poor obstetric history  
 Maternal disease/death 
 Hypertension 
 Maternal infection 
 Oligo/polyhydramnios 
 Excessive bleeding per vagina 
 Abnormal fetal monitoring 
 In utero therapy 
 Maternal toxin exposure 
 Abnormal placenta noted at delivery 
  
ANNEXURE III 
 
I. HAEMATOXYLIN AND EOSIN STAINING  
 Fixation  – 10% Formalin  
 Technic  – Paraffin section cut at 4 microns   
 
SOLUTION PREPARATION  
 
 Haematoxylin - 10gram is dissolved in Absolute alcohol - 100ml with light 
heat. Aluminum Potassium sulphate 200 gram dissolved in 2 liters of warm distilled 
water. Both were mixed and boiled: 5 gms of mercuric oxide was added while boiling 
and cooled after two minutes. Prior to use, 3 ml of acetic acid for 100 ml of 
hematoxylin was added.  
 
1% ACID ALCOHOL  
70% alcohol - 990 ml.  
Con.HCI - 10 ml. 
 
Eosin  
Eosin - 10 gram  dissolved 
D.H2O - 100 ml.   
 
 
Phloxine ‘B’ - 100 mg  dissolved 
D.H2O - 20 ml   
 
 Both were mixed and 780 ml of 90% alcohol was added. 4 ml of glacial cetic 
acid and saturated Lithium carbonate were added.   
 
PROCEDURE  
1. The slide was kept in xyline for 15 minutes.  
2. It was washed in graded alcohol absolute 90% : 80% each 2 dips  
3. Slide was washed in water for 5 minutes.  
4. Stained in haematoxylin for 5 minutes.  
5. It was washed in water for 5 minutes.  
6. Differentiated in 1% acid alcohol 2 dips  
7. Washed in water for 2 minutes.  
8. Dipped twice in Lithium carbonate for blueing  
9. Washed in water for 10 minutes  
10. Dipped in 80% alcohol  
11. Stained with eosin for 5 minutes.  
12. Dehydrated in graded alcohol 80%, 90% then absolute alcohol  
13. Cleared in xylene.  
14. Mounted in D.P.X.   
 
Result  
 Nuclei   -  Blue  
 Cytoplasm   -   Pink 
Master Chart 
  
  
  
  
  
  
  
  
  
  
  
 
  
 
KEY TO MASTER CHART 
 
 
G   : GRAVIDITY 
P   : PARITY 
L    : LIVE 
A   : ABORTION 
B.P   : BLOOD PRESSURE 
LB   : LIVE BIRTH 
SB   : STILL BIRTH 
“+”   : PRESENT 
“-“   : ABSENT 
LPF   : LOW POWER FIELD 
